Advertisement
Advertisement
U.S. Markets close in 3 hrs 19 mins
Advertisement
Advertisement
Advertisement
Advertisement

Verve Therapeutics, Inc. (VERV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
21.47-1.28 (-5.63%)
As of 12:41PM EST. Market open.
Advertisement
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2022)Next Qtr. (Dec 2022)Current Year (2022)Next Year (2023)
No. of Analysts8887
Avg. Estimate-0.74-0.74-2.95-2.84
Low Estimate-0.87-0.87-3.21-3.22
High Estimate-0.64-0.63-2.74-2.3
Year Ago EPS-0.47-0.65-4.48-2.95
Revenue EstimateCurrent Qtr. (Sep 2022)Next Qtr. (Dec 2022)Current Year (2022)Next Year (2023)
No. of Analysts4455
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History9/29/202112/30/20213/30/20226/29/2022
EPS Est.-0.45-0.55-0.66-0.65
EPS Actual-0.47-0.65-0.62-0.84
Difference-0.02-0.10.04-0.19
Surprise %-4.40%-18.20%6.10%-29.20%
EPS TrendCurrent Qtr. (Sep 2022)Next Qtr. (Dec 2022)Current Year (2022)Next Year (2023)
Current Estimate-0.74-0.74-2.95-2.84
7 Days Ago-0.74-0.74-2.95-2.84
30 Days Ago-0.75-0.75-2.97-2.86
60 Days Ago-0.7-0.74-2.66-2.95
90 Days Ago-0.7-0.74-2.66-2.95
EPS RevisionsCurrent Qtr. (Sep 2022)Next Qtr. (Dec 2022)Current Year (2022)Next Year (2023)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesVERVIndustrySector(s)S&P 500
Current Qtr.-57.40%N/AN/AN/A
Next Qtr.-13.80%N/AN/AN/A
Current Year34.20%N/AN/AN/A
Next Year3.70%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A
Advertisement
Advertisement